Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.792
-0.045 (-5.40%)
Apr 29, 2026, 11:54 AM EDT - Market open
Aprea Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 14.6 | 22.85 | 21.61 | 28.79 | 53.08 | Upgrade
|
| Cash & Short-Term Investments | 14.6 | 22.85 | 21.61 | 28.79 | 53.08 | Upgrade
|
| Cash Growth | -36.11% | 5.75% | -24.94% | -45.76% | - | Upgrade
|
| Prepaid Expenses | 0.96 | 0.73 | 0.91 | 1.37 | 3.51 | Upgrade
|
| Total Current Assets | 15.56 | 23.58 | 22.52 | 30.15 | 56.58 | Upgrade
|
| Property, Plant & Equipment | 0.06 | 0.08 | 0.09 | 0 | 0.21 | Upgrade
|
| Other Long-Term Assets | 0.31 | 0.32 | 0.04 | - | 0.03 | Upgrade
|
| Total Assets | 15.93 | 23.98 | 22.65 | 30.16 | 56.82 | Upgrade
|
| Accounts Payable | 0.71 | 1.35 | 1.67 | 0.84 | 1.77 | Upgrade
|
| Accrued Expenses | 2.05 | 2.01 | 2.19 | 2.36 | 5.35 | Upgrade
|
| Current Portion of Leases | - | - | - | - | 0.19 | Upgrade
|
| Current Unearned Revenue | - | - | 0.53 | - | - | Upgrade
|
| Total Current Liabilities | 2.76 | 3.36 | 4.39 | 3.2 | 7.32 | Upgrade
|
| Total Liabilities | 2.76 | 3.36 | 4.39 | 3.2 | 7.32 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 356.71 | 350.97 | 335.64 | 330.06 | 241 | Upgrade
|
| Retained Earnings | -333.64 | -321.04 | -308.08 | -293.8 | -181.13 | Upgrade
|
| Comprehensive Income & Other | -10.63 | -10.63 | -10.61 | -10.62 | -10.36 | Upgrade
|
| Total Common Equity | 12.44 | 19.31 | 16.95 | 25.64 | 49.51 | Upgrade
|
| Shareholders' Equity | 13.17 | 20.62 | 18.26 | 26.95 | 49.51 | Upgrade
|
| Total Liabilities & Equity | 15.93 | 23.98 | 22.65 | 30.16 | 56.82 | Upgrade
|
| Total Debt | - | - | - | - | 0.19 | Upgrade
|
| Net Cash (Debt) | 14.6 | 22.85 | 21.61 | 28.79 | 52.89 | Upgrade
|
| Net Cash Growth | -36.11% | 5.75% | -24.94% | -45.57% | - | Upgrade
|
| Net Cash Per Share | 2.23 | 4.15 | 5.97 | 17.37 | 49.69 | Upgrade
|
| Filing Date Shares Outstanding | 11.45 | 5.49 | 5.43 | 3.73 | 1.06 | Upgrade
|
| Total Common Shares Outstanding | 8.19 | 5.48 | 3.74 | 2.66 | 1.06 | Upgrade
|
| Working Capital | 12.8 | 20.22 | 18.14 | 26.95 | 49.27 | Upgrade
|
| Book Value Per Share | 1.52 | 3.52 | 4.54 | 9.66 | 45.97 | Upgrade
|
| Tangible Book Value | 12.44 | 19.31 | 16.95 | 25.64 | 49.51 | Upgrade
|
| Tangible Book Value Per Share | 1.52 | 3.52 | 4.54 | 9.66 | 45.97 | Upgrade
|
| Machinery | 0.15 | 0.15 | 0.14 | 0.05 | 0.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.